跳至主要内容
临床试验/NCT06297915
NCT06297915已完成不适用

Evaluation and Comparison of the Effectiveness of Ketamine and Lidocaine Infusion in Peripheral Neuropathic Pain: A Retrospective Study

Hacettepe University1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2022年5月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
102
试验地点
1
主要终点
Neuropathic Pain Scale

研究概览

简要总结

This study aimed to evaluate and compare the efficacy of ketamine and lidocaine infusion in patients with chronic peripheral neuropathic pain.

Patients who received intravenous ketamine infusion and the other patient group who received intravenous lidocaine infusion were evaluated in the study. Pain scores and quality of life were assessed with scales before treatment at two weeks, two months, and six months after treatment.

详细描述

This study, it was aimed to evaluate and compare the efficacy of intravenous infusion of ketamine and lidocaine, which have been known and used in pain management and which have recently increased interest in the treatment of peripheric neuropathic pain.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years of age
  • Patients with peripheral neuropathic pain (radicular neuropathy, diabetic neuropathy, complex regional pain syndrome type 2, traumatic peripheral nerve injury, trigeminal neuralgia, postherpetic neuralgia)
  • Patients who was evaluated by DN4 scores with of ≥4 points

排除标准

  • Patients with central nervous system disease .
  • Patients with cancer related neuropatic pain.
  • Patients with central neuropathic pain patterns.
  • Patients with renal, hepatic, cardiovascular, and psychiatric diseases.
  • Patients whose treatment could not be completed due to side effects or other reasons.
  • Patients who had lost their follow-up .

结局指标

主要结局

Neuropathic Pain Scale

时间窗: Before treatment at two weeks, two months, and six months after treatment.The 7 symptoms items are scored by interviewing the patient.The scores are added and a score of 4 or more outout of ,10 point (severe pain ) is suggestive of neuropathic pain.

Neuropathic Pain 4 Questions (DN4)

Pain Rating Scale

时间窗: Before treatment at two weeks, two months, and six months after treatment.NRS in which individuals rate their pain on an ten-point numerical scale. Zero:''no pain at all' ten-point ''severe pain''

Numeric Rating Scale

次要结局

  • Quality of Life Scale(Before treatment at two weeks, two months, and six months after treatment.12-question survey PCS and the MCS Scores above 50 indicate a better-than-average health-related quality of life, while scores below 50 suggest below-average health.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tugce Yavuz

Medical Doctor

Hacettepe University

研究点 (1)

Loading locations...

相似试验